Pharma news
Americas
Many NPEs have been using their well-stocked war chests to build massive patent portfolios in the medical technology sector, so right owners need to be prepared for a fresh wave of litigation. Jay Nuttall of Steptoe & Johnson offers some tips. 7 May 2015
Americas
The US Supreme Court has rejected pharmaceutical company Bristol-Myers Squibb’s appeal to review a ruling that found its patent covering a treatment for hepatitis B invalid. 6 May 2015
Americas
Law firm Fish & Richardson has added patent attorney Lisa Chiarini to its intellectual property litigation group. 5 May 2015
Pharma
The English High Court has ruled that a patent covering Novartis’s transdermal patch treatment for Alzheimer’s disease, Exelon, is invalid. 29 April 2015
Americas
A US court has ruled on how five claims in two patents related to acne drug Absorica should be construed, in a patent infringement case between Canada-based Cipher Pharmaceuticals and Actavis. 28 April 2015
Americas
Hedge fund manager Kyle Bass and his Coalition for Affordable Drugs is continuing its campaign against certain pharmaceutical patents, most recently seeking to invalidate patents owned by Celgene and NPS Pharma. 27 April 2015
Americas
Drug maker Shire, alongside two other companies, has sued Amneal Pharmaceuticals for allegedly infringing a patent related to Lialda, a drug for treating ulcerative colitis. 24 April 2015
Americas
Texas hedge fund manager Kyle Bass has sought another inter partes review, this time to challenge a patent covering Pharmacyclics’ cancer drug Imbruvica. 22 April 2015
Pharma
Law firm Taylor Wessing has promoted senior associates Matt Royle and Ed Vickers to partner and senior counsel, respectively. 21 April 2015
Americas
An Ontario-based company has sued Allergan for allegedly infringing a method patent that protects the use of cosmetic drug Botox to treat back pain. 20 April 2015